the gormley files

Sep 19, 2018: The Gormley Files – Preserving Our Natural Resources Preserves Health

Good news! The bill referred to below passed the Senate on October 10 – thanks to all who sent messages to their Senators! Read more here: https://mast.house.gov/blog?ID=021535EC-B791-4B8E-857F-BEA2B12FAD18 Senate Must Pass The Water Resources Development Act by James J. Gormley Fixing our water issues is perhaps the most important priority for the state of Florida, the region and the country. On…

May 27, 2018: The Gormley Files – Escape from the Emergency Room

Escape from the Emergency Room By James J. Gormley A few years back, I realized that I had a medical “situation,” a male concern I had wondered about for a couple of months, yet had dealt with by the time-honored male tradition of “avoidance” — if I pretend everything’s okay, the problem will go away — not the best approach….

Apr 23, 2018: The Gormley Files – YOU Are the Truth Champions

YOU Are the Truth Champions By James J. Gormley Facts. Truth. What is it about versions of these words that have had shifting uses and meanings throughout the millennia? They have been morphed into tools of propaganda, instruments of oppression and even edicts from kings or despots—who say what they decide is the truth. Many of us who are believers…

Jan 11, 2018: CFH VP James Gormley Shares a New Year Message

Happy New Year to all of our supporters, friends, allies and readers. Now that the wrapping paper is gone and noisemakers are stowed, we wanted to send this very brief note looking back at (and forward to) a few issues relating to natural products, health and the environment. First, there is general uncertainty as to whether the anti-over-regulatory winds in…

Aug 13, 2012: An Open Letter to Consumer Reports: 10 Misinformation Hazards in Your “10 Surprising Dangers of Vitamins and Supplements” Article

By James J. Gormley It is personally disappointing for me that Consumer Reports, the flagship of the respected marketplace-empowerment organization, Consumers Union, has once again seen fit to arm the American consumer with detrimental misinformation regarding safe, beneficial food supplements. In the alarmist piece which appears in the September 2012 issue, the anti-supplement subtitle reads: “Don’t assume they’re safe because…

May 09, 2012: The FDA’s DMAA Gamble

By James J. Gormley Courtesy of the SupplySide Community On April 24th, the U.S. Food and Drug Administration (FDA) sent warning letters to 10 companies cautioning them, in the strictest possible terms, that their DMAA (1,3 Dimethylamylamine)-containing products may be considered new dietary ingredients for which notifications have not been submitted and, so, would be adulterated products in violation of…

Sep 13, 2011: The FDA’s Plan to Cripple the Health Food Industry: Their New War Has Begun

September 13, 2011 By James J. Gormley, Vice President and Senior Policy Advisor, Citizens for Health According to a July 7, 2011 report from the U.S. Food and Drug Administration (FDA), Pathway to Global Product Safety and Quality, government spending on healthcare has been on the rise since at least 1990 in the world’s leading economies. U.S. Medicare spending is…

Aug 23, 2011: What’s old is new again? The FDA takes aim at modern science and innovation

By James Gormley, Senior Policy Advisor, Citizens for Health On January 4th, 2011, the Food Safety Modernization Act (FSMA) was signed into law. It included a number of requirements, including one that the FDA issue industry guidance as to when companies need to submit New Dietary Ingredient (NDI) notifications to the agency and when they do not, and about 186…

Jun 16, 2011: The FDA: A Warning Letter From American Taxpayers

By James J. Gormley From American Chronicle In June 2007, the U.S. Food and Drug Administration (FDA) issued the final rule on Current Good Manufacturing Practices (cGMPs), which, according to Nutraingredients-usa.com, is regarded by many as “the most important regulatory development for the dietary supplement industry in over a decade.” Vasilos Frankos, Ph.D, outgoing director of the FDA’s Division of…